首页> 美国卫生研究院文献>Frontiers in Oncology >Stem Cells and Cellular Origins of Breast Cancer: Updates in the Rationale, Controversies, and Therapeutic Implications
【2h】

Stem Cells and Cellular Origins of Breast Cancer: Updates in the Rationale, Controversies, and Therapeutic Implications

机译:乳腺癌的干细胞和细胞起源:原理,争议和治疗意义的更新。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Breast cancer stem cells have been known to contribute immensely to the carcinogenesis of the breast and therapeutic resistance in the clinic. Current studies show that the population of breast cancer stem cells is heterogeneous, involving various cellular markers and regulatory signaling pathways. In addition, different subtypes of breast cancer exhibit distinct subtypes and frequencies of breast cancer stem cells. In this review, we provide an overview of the characteristics of breast cancer stem cells, including their various molecular markers, prominent regulatory signaling, and complex microenvironment. The cellular origins of breast cancer are discussed to understand the heterogeneity and diverse differentiations of stem cells. Importantly, we also outline the recent advances and controversies in the therapeutic implications of breast cancer stem cells in different subtypes of breast cancer.
机译:在临床上,已知乳腺癌干细胞极大地促进了乳腺癌的致癌作用和治疗抗性。当前的研究表明,乳腺癌干细胞的群体是异质的,涉及各种细胞标志物和调控信号通路。另外,乳腺癌的不同亚型表现出乳腺癌干细胞的不同亚型和频率。在这篇综述中,我们概述了乳腺癌干细胞的特征,包括它们的各种分子标记,突出的调控信号和复杂的微环境。讨论了乳腺癌的细胞起源,以了解干细胞的异质性和多样化分化。重要的是,我们还概述了乳腺癌干细胞在不同乳腺癌亚型中的治疗作用的最新进展和争议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号